THIS NEW HOPE FOR WEIGHT CONTROL ?

Experts are increasingly examining retatrutide, a promising medication developed by Eli Lilly, as a potential advance in body management. Different than many earlier approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, hormones that impact satiety and blood sugar co